BackImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies Cost of Revenue

Cost of Revenue analysis for IPA.

Quarterly Cost of Revenue

$1.67M
↓ 41.65% YoY

As of Jan 31, 2026

Annual Cost of Revenue (TTM)

$7.30M
↓ 38.16% YoY

Trailing 12 months ending Jan 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin